Development of a lateral flow device for the detection of CMV in Urine
Research type
Research Study
Full title
Development of a low-cost, easy to use lateral flow device suitable for large scale screening of human cytomegalovirus in newborn babies
IRAS ID
198912
Contact name
Nick Roesen
Contact email
Sponsor organisation
The Native Antigen Company
Duration of Study in the UK
2 years, 11 months, 31 days
Research summary
Human cytomegalvirus is a member of the herpes family and is now the leading cause of congenital infection in the UK and as such can cause permenant disabilities, such as developmental problems and hearing loss. Early detection allows for more timely clinical interventions and in severe cases, treatment. This project is to develop a novel non invasive, low cost point of care diagnostic device to detect the presence of CMV in urine samples from neonates.
REC name
London - Harrow Research Ethics Committee
REC reference
16/LO/0704
Date of REC Opinion
27 Apr 2016
REC opinion
Further Information Favourable Opinion